autologous anti-EBV CAR T cells BRG01
Term · Oncology and biomedicine · MLC-T-ONC-011422
A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) targeting an Epstein-Barr virus (EBV) protein, with potential immunostimulating and antineoplastic activities. Upon intravenous administration, the autologous anti-EBV CAR T cells BRG01 targets a specific EBV protein expressed on EBV-positive cancer cells and promotes killing of these cancer cells. EBV infection is associated with various cancers and the expression of certain EBV specific proteins plays a key role in tumor cell proliferation and survival.
| Identifier | MLC-T-ONC-011422 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous anti-EBV CAR-T cells BRG01 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011422",
"term": "autologous anti-EBV CAR T cells BRG01",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) targeting an Epstein-Barr virus (EBV) protein, with potential immunostimulating and antineoplastic activities. Upon intravenous administration, the autologous anti-EBV CAR T cells BRG01 targets a specific EBV protein expressed on EBV-positive cancer cells and promotes killing of these cancer cells. EBV infection is associated with various cancers and the expression of certain EBV specific proteins plays a key role in tumor cell proliferation and survival.",
"synonyms": [
"autologous anti-EBV CAR-T cells BRG01"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-anti-ebv-car-t-cells-brg01/"
}
Record 2,754 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.